Phase II trial of XmAb20717 (vudalimab) in patients with advanced biliary tract cancers

被引：0
|
作者：
Chapin, William Joseph [1 ]
Agarwal, Parul [1 ]
DiCicco, Lisa [1 ]
Palmer, Rayleigh [1 ]
Cenou, Nadia [1 ]
Huang, Alexander Chan Chi [1 ]
Karasic, Thomas Benjamin [1 ]
机构：
[1] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4184
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Role of precision medicine for patients with advanced biliary tract cancers
    Hollebecque, Antoine
    Nabi, Oumrou
    Ducreux, Michel
    Boige, Valerie
    Scoazec, Jean-Yves
    Rouleau, Etienne
    Boileve, Alice
    Smolenschi, Cristina
    Verlingue, Loic
    Matias, Margarida
    Burtin, Pascal
    Prieux-Klotz, Caroline
    Massard, Christophe
    Malka, David
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [32] A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers
    Laura W. Goff
    Dana B. Cardin
    Jennifer G. Whisenant
    Liping Du
    Tatsuki Koyama
    Kimberly B. Dahlman
    Safia N. Salaria
    Ruth T. Young
    Kristen K. Ciombor
    Jill Gilbert
    Stephen James Smith
    Emily Chan
    Jordan Berlin
    Investigational New Drugs, 2017, 35 : 95 - 104
  • [33] A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers
    Goff, Laura W.
    Cardin, Dana B.
    Whisenant, Jennifer G.
    Du, Liping
    Koyama, Tatsuki
    Dahlman, Kimberly B.
    Salaria, Safia N.
    Young, Ruth T.
    Ciombor, Kristen K.
    Gilbert, Jill
    Smith, Stephen James
    Chan, Emily
    Berlin, Jordan
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (01) : 95 - 104
  • [34] Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers
    Yoo, Changhoon
    Javle, Milind M.
    Mata, Helena Verdaguer
    de Braud, Filippo
    Trojan, Jorg
    Raoul, Jean-Luc
    Kim, Jin Won
    Ueno, Makoto
    Lee, Choong-kun
    Hijioka, Susumu
    Cubillo, Antonio
    Furuse, Junji
    Azad, Nilofer
    Sato, Masashi
    Vugmeyster, Yulia
    Machl, Andreas
    Bajars, Marcis
    Bridgewater, John
    Oh, Do-Youn
    Borad, Mitesh J.
    HEPATOLOGY, 2023, 78 (03) : 758 - 770
  • [35] Randomized phase II trial of the carboxylesterase (CES)-converted novel drug EDO-S7.1 in patients (pts) with advanced biliary tract cancers (BTC)
    Pape, Ulrich-Frank
    Kasper, Stefan
    Meiler, Johannes
    Sinn, Marianne
    Vogel, Arndt
    Mueller, Lothar
    Burkhard, Oswald
    Caca, Karel
    Heeg, Steffen
    Laval, Victor Rodriguez
    Kuhl, Anya A.
    Arsenic, Ruza
    Jansen, Holger
    Utku, Nalan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [36] Phase I/II clinical trial of regorafenib plus durvalumab (MEDI4736) in patients with chemotherapy-refractory advanced biliary tract cancers.
    Al-Rajabi, Raed Moh'd Taiseer
    Kasi, Anup
    Baranda, Joaquina Celebre
    Saeed, Anwaar
    Li, Haoran
    Bruey, Collin
    Best, Shaun
    Phadnis, Milind A.
    Sun, Weijing
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS581 - TPS581
  • [37] Final analysis of phase II trial of regorafenib (REG) in refractory advanced biliary cancers (BC).
    Kim, Dae Won
    Sanoff, Hanna Kelly
    Poklepovic, Andrew Stewart
    Tariq, Fatima
    Nixon, Andrew B.
    Liu, Yingmiao
    Kim, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] Phase II study of anlotinib plus sintlimab as second-line treatment for patients with advanced biliary tract cancers.
    Zong Hong
    Zhong Qian
    Zhao Ruihua
    Jin Shuiling
    Zhou Chuang
    Zhang Xiaojian
    Shi Jianxiang
    Qiao Shishi
    Han Jinming
    Jiang Miao
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [39] A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers.
    Gebbia, N
    Verderame, F
    Di Leo, R
    Santangelo, D
    Cicero, G
    Valerio, MR
    Arcara, C
    Badalamenti, G
    Fulfaro, F
    Carreca, I
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 340S - 340S
  • [40] Phase II trial of trifluridine/tipiracil and irinotecan for the treatment of advanced refractory biliary tract cancer
    Xie, Hao
    Borad, Mitesh J.
    Ahn, Daniel H.
    Bekaii-Saab, Tanios S.
    Tran, Nguyen H.
    Jin, Zhaohui
    Pitot, Henry C.
    Huebner, Lucas J.
    Shi, Qian
    Wessling, Jaclynn
    Durgin, Lori M.
    Liu, Minetta C.
    Hogenson, Tara L.
    Phillips, William J.
    Fernandez-Zapico, Martin
    Alberts, Steven R.
    Mahipal, Amit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345